{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T19:37:28Z","timestamp":1776713848843,"version":"3.51.2"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004032","name":"Jilin University","doi-asserted-by":"publisher","award":["201307049"],"award-info":[{"award-number":["201307049"]}],"id":[{"id":"10.13039\/501100004032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007847","name":"Science Foundation of Jilin Province, China","doi-asserted-by":"publisher","award":["2015508"],"award-info":[{"award-number":["2015508"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.lfs.2016.01.037","type":"journal-article","created":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T07:15:20Z","timestamp":1453792520000},"page":"97-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Hepatic IGF-1R overexpression combined with the activation of GSK-3\u03b2 and FOXO3a in the development of liver cirrhosis"],"prefix":"10.1016","volume":"147","author":[{"given":"Wentao","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuewen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changyong","family":"E","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2016.01.037_bb0005","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2016.01.037_bb0010","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2016.01.037_bb0015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0140-6736(12)61285-9","article-title":"Hepatocellular carcinoma","volume":"380","author":"Oliveri","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2016.01.037_bb0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1210\/edrv-10-1-68","article-title":"Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations","volume":"10","author":"Daughaday","year":"1989","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.lfs.2016.01.037_bb0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fphys.2014.00357","article-title":"Mechanistic target of rapamycin (mTOR): a point of convergence in the action of insulin\/IGF-1 and G protein-coupled receptor agonists in pancreatic cancer cells","volume":"5","author":"Rozengurt","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2016.01.037_bb0030","first-page":"9","article-title":"Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3?","volume":"7","author":"Zielinska","year":"2015","journal-title":"Breast Cancer (Dove Med. Press)"},{"key":"10.1016\/j.lfs.2016.01.037_bb0035","article-title":"MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS\/RAF\/ERK signaling pathways","author":"Xu","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2016.01.037_bb0040","first-page":"527","article-title":"Type 1 insulin-like growth factor receptor monoclonal antibody (HX-1162) treatment for liver cancer","volume":"6","author":"Chen","year":"2013","journal-title":"Oncol. Targets Ther."},{"key":"10.1016\/j.lfs.2016.01.037_bb0045","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1158\/1078-0432.CCR-07-4879","article-title":"The type 1 insulin-like growth factor receptor pathway","volume":"14","author":"Chitnis","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2016.01.037_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2015.05.006","article-title":"Glycogen synthase kinase-3: a potential preventive target for prostate cancer management","author":"Li","year":"2015","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.lfs.2016.01.037_bb0055","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2174\/138945011796150307","article-title":"The complex biology of FOXO","volume":"12","author":"Monsalve","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.lfs.2016.01.037_bb0060","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s003350020002","article-title":"Identification and characterization of members of the FKHR (FOX O) subclass of winged-helix transcription factors in the mouse","volume":"12","author":"Biggs","year":"2001","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.lfs.2016.01.037_bb0065","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2016.01.037_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/onc.2015.42","article-title":"The DEAD box protein p68: a crucial regulator of AKT\/FOXO3a signaling axis in oncogenesis","author":"Sarkar","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2016.01.037_bb0075","doi-asserted-by":"crossref","first-page":"24759","DOI":"10.1074\/jbc.M114.580738","article-title":"GSK3 protein positively regulates type I insulin-like growth factor receptor through forkhead transcription factors FOXO1\/3\/4","volume":"289","author":"Huo","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2016.01.037_bb0080","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3748\/wjg.v9.i6.1287","article-title":"Expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor and its intervention by interleukin-10 in experimental hepatic fibrosis","volume":"9","author":"Wang","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2016.01.037_bb0085","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1478-3231.2010.02428.x","article-title":"Insulin-like growth factor-I and the liver","volume":"31","author":"Bonefeld","year":"2011","journal-title":"Liver Int."},{"key":"10.1016\/j.lfs.2016.01.037_bb0090","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2265.2009.03707.x","article-title":"Ascites from patients with alcoholic liver cirrhosis contains higher IGF-I bioactivity than serum","volume":"72","author":"Jeyaratnaganthan","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.lfs.2016.01.037_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1517\/14728222.2011.638626","article-title":"Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy","volume":"16","author":"Tognon","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.lfs.2016.01.037_bb0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3816\/CCC.2010.n.032","article-title":"The insulin-like growth factor signaling pathway as a target for treatment of colorectal carcinoma","volume":"9","author":"Ewing","year":"2010","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.lfs.2016.01.037_bb0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2014.12.034","article-title":"Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K\/Akt\/FoxO3a signalling in experimental colon cancer","volume":"359","author":"Qazi","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2016.01.037_bb0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jbior.2013.09.006","article-title":"Class I PI 3-kinases signaling in platelet activation and thrombosis: PDK1\/Akt\/GSK3 axis and impact of PTEN and SHIP1","volume":"54","author":"Laurent","year":"2014","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.lfs.2016.01.037_bb0115","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hep.23412","article-title":"Insulin-like growth factor I gene transfer to cirrhotic liver induces fibrolysis and reduces fibrogenesis leading to cirrhosis reversion in rats","volume":"51","author":"Sobrevals","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2016.01.037_bb0120","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jhep.2005.03.025","article-title":"Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial","volume":"43","author":"Conchillo","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2016.01.037_bb0125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc1387","article-title":"Insulin-like growth factors and neoplasia","volume":"4","author":"Pollak","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2016.01.037_bb0130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5732\/cjc.012.10263","article-title":"IGF-1R as an anti-cancer target\u2013trials and tribulations","volume":"32","author":"Chen","year":"2013","journal-title":"Chin. J. Cancer"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516300376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516300376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T07:02:08Z","timestamp":1748761328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320516300376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":26,"alternative-id":["S0024320516300376"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2016.01.037","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic IGF-1R overexpression combined with the activation of GSK-3\u03b2 and FOXO3a in the development of liver cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2016.01.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}